Literature DB >> 28295439

Genome Engineering and Modification Toward Synthetic Biology for the Production of Antibiotics.

Xuan Zou1,2, Lianrong Wang1, Zhiqiang Li1, Jie Luo2, Yunfu Wang2, Zixin Deng1, Shiming Du2, Shi Chen1,2.   

Abstract

Antibiotic production is often governed by large gene clusters composed of genes related to antibiotic scaffold synthesis, tailoring, regulation, and resistance. With the expansion of genome sequencing, a considerable number of antibiotic gene clusters has been isolated and characterized. The emerging genome engineering techniques make it possible towards more efficient engineering of antibiotics. In addition to genomic editing, multiple synthetic biology approaches have been developed for the exploration and improvement of antibiotic natural products. Here, we review the progress in the development of these genome editing techniques used to engineer new antibiotics, focusing on three aspects of genome engineering: direct cloning of large genomic fragments, genome engineering of gene clusters, and regulation of gene cluster expression. This review will not only summarize the current uses of genomic engineering techniques for cloning and assembly of antibiotic gene clusters or for altering antibiotic synthetic pathways but will also provide perspectives on the future directions of rebuilding biological systems for the design of novel antibiotics.
© 2017 Wiley Periodicals, Inc.

Keywords:  antibiotics; genome engineering; genome modification; synthetic biology

Mesh:

Substances:

Year:  2017        PMID: 28295439     DOI: 10.1002/med.21439

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  3 in total

1.  Occurrence, evolution, and functions of DNA phosphorothioate epigenetics in bacteria.

Authors:  Tong Tong; Si Chen; Lianrong Wang; You Tang; Jae Yong Ryu; Susu Jiang; Xiaolin Wu; Chao Chen; Jie Luo; Zixin Deng; Zhiqiang Li; Sang Yup Lee; Shi Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

2.  An aurora of natural products-based drug discovery is coming.

Authors:  Yaojun Tong; Zixin Deng
Journal:  Synth Syst Biotechnol       Date:  2020-06-06

Review 3.  CRISPR/Cas9-Based Editing of Streptomyces for Discovery, Characterization, and Production of Natural Products.

Authors:  Weixin Tao; Anna Yang; Zixin Deng; Yuhui Sun
Journal:  Front Microbiol       Date:  2018-07-24       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.